Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Broker tips: BAE Systems, PZ Cussons, Spirax-Sarco
(Sharecast News) - Analysts at Citi reinstated their 'neutral' rating on defence group BAE Systems on Friday, updating its forecasts following the company's acquisition of Ball Aerospace. Citi said over the last couple of years, BAE Systems medium-term outlook has accelerated from low/mid-single digit to mid/high single digit as its pipeline expanded. In addition, Citi expects this growth to be "relatively capital light", resulting in strong cash conversion.
However, the bank said its share price has already largely reflected this and the roughly 10% upside to its new target price of 1,400.0p does not merit a 'buy' recommendation.
"Pushing the scenarios towards the upper end of realistic expectations does give more attractive upside to 1,600.0p but we consider this to be in 'everything has to right' territory; conversely, our downside scenario, which is approaching the realms of the bottom end of realistic expectations, gives fair value of 1,070.0p," said Citi.
Barclays downgraded shares of Imperial Leather maker PZ Cussons on Friday to 'equalweight' from 'overweight' and slashed the price target to 111.0p from 205.0p, citing "too much" Nigerian exposure.
The Naira devaluation has brought more issues with a weakening macro backdrop, which continues to weigh heavily on PZ, Barclays said.
"Underwhelming contributions from beauty and Indonesia, low stock liquidity and a lack of catalysts leave us looking elsewhere."
Analysts at Berenberg raised their target price on manufacturer Spirax-Sarco Engineering from 8,800.0p to 9,800.0p on Friday after the group's full-year results came in line with expectations.
Berenberg noted that organic guidance was "slightly better than consensus", but with near-term offsets in FX, interest, and tax which dragged its earnings per share forecasts lower.
"We think the guidance is good in the context of the current market environment, albeit with the caveat of H2-weighting and caution about a global industrial production recovery in H2 2024," said Berenberg. "Management's apparent confidence in returning to growth in the semiconductors business is a slight improvement versus previous management commentary in our view, but bakes in some management hope ahead of actual evidence of this."
The German bank noted that there were "many moving parts" in terms of cost actions, investment, and organic developments, but stated that guidance still appears to be a "slight net positive" at the organic level and said it "can understand" yesterday's positive reaction in shares, even if perhaps it was "a bit stronger" than it had expected.
That said, Berenberg stated that while the "commentary and confident presentation" addressed some of the concerns it had in parts of the Spirax businesses, there were still further developments that it believes need to take place to justify the current valuation.
"We make small changes to earnings reflecting slightly better organic guidance offset by FX/interest/tax. The stock now trades on 33.2x 2024 P/E, 23x EV/EBIT and 1.7% FCF yield," said Berenberg, which reiterated its 'hold' rating on the stock.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.